C
CPRX
Catalyst Pharmaceuticals Inc
24.94
-0.66-2.58%After Hours: 24.81 -0.13 -0.52%19:52 04/10 EDT
OPEN/PREV CLOSE25.54/25.60
TODAY RANGE24.83-25.57
VOL1.28M
MARKET CAP3.05B
52 WEEK RANGE19.05-26.58
AVG VOL (3M)1.22M
% TURNOVER1.05%
TURNOVER--
P/E (TTM)14.81
% RANGE2.89%
EPS(TTM)1.684
P/E(FORWARD)13.20
P/B3.202
BVPS7.79
DIVIDEND--
P/S5.19
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.86B
SHARES OUTSTANDING122.12M
NEXT EARNINGS05/05-05/11
FREE FLOAT114.57M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·04/02 14:00
5 Small Drug Stocks to Buy as Sector Recovery Gains Strength
NASDAQ·03/31 09:28
New Strong Buy Stocks for March 31st
NASDAQ·03/31 07:56
Best Value Stocks to Buy for March 31st
NASDAQ·03/27 15:30
Catalyst (CPRX) Down 2.5% Since Last Earnings Report: Can It Rebound?
NASDAQ·03/26 17:14
SRPT Stock Surges on Promising Early Results From siRNA Programs
Dow Jones·03/25 20:35
Catalyst Pharmaceuticals Inc. Stock Advances 3.2%, Outperforms Peers
NASDAQ·03/25 16:24
NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data
NASDAQ·03/25 12:23
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims
NASDAQ·03/24 16:12
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study
NASDAQ·03/20 12:10
FDA Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients
TipRanks·03/18 22:06
Catalyst Pharma Patent Trial Against Hetero USA Delayed
Same Industry